Holen Sie sich die Stockscreener-App
33.88
0.68%
0.2285
Handel nachbörslich:
33.88
-0.0048
-0.01%
Schlusskurs vom Vortag:
$33.66
Offen:
$33.8848
24-Stunden-Volumen:
22
Relative Volume:
0.02
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.77%
1M Leistung:
-5.15%
6M Leistung:
+11.98%
1J Leistung:
+18.56%
1-Tages-Spanne:
$33.88
$33.88
1-Wochen-Bereich:
$33.66
$34.75
52-Wochen-Spanne:
$23.74
$38.17
Franklin Genomic Advancements Etf Stock (HELX) Company Profile
Firmenname
Franklin Genomic Advancements Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare HELX vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HELX
Franklin Genomic Advancements Etf
|
33.88 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
338.19 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
685.13 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
688.28 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
275.40 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
610.75 | 124.43B | 0 | 0 | 0 | 0.00 |
Franklin Genomic Advancements Etf Aktie (HELX) Neueste Nachrichten
Understanding the Setup: (HELX) and Scalable Risk - Stock Traders Daily
The Technical Signals Behind (HELX) That Institutions Follow - Stock Traders Daily
HELX Should I Buy - Intellectia AI
Precision Trading with Franklin Genomic Advancements Etf (HELX) Risk Zones - Stock Traders Daily
Technical Reactions to HELX Trends in Macro Strategies - Stock Traders Daily
Trading the Move, Not the Narrative: (HELX) Edition - Stock Traders Daily
Franklin Universal Trust (NYSE: FT) details 2026 trustee election - Stock Titan
How Franklin Genomic Advancements ETF stock valuation compares with sectorDollar Strength & High Accuracy Swing Entry Alerts - Улправда
Aug Shorts: How Franklin Genomic Advancements ETF stock valuation compares with sector2025 Year in Review & Long-Term Safe Return Strategies - Улправда
(HELX) Volatility Zones as Tactical Triggers - Stock Traders Daily
Franklin Genomic Advancements ETF (HELX) Dividend Yield 2026 & History - MarketBeat
Is Franklin Genomic Advancements ETF stock a defensive play amid uncertaintyPortfolio Value Summary & Growth Focused Entry Point Reports - Улправда
Inside the Recent Strength in Biotech ETFs - MSN
Is Franklin Genomic Advancements ETF stock included in top ETFs2025 Big Picture & Fast Moving Stock Watchlists - Улправда
What downside risks could hit Franklin Genomic Advancements ETF stockWeekly Trade Recap & Daily Chart Pattern Signals - Newser
Trading Systems Reacting to (HELX) Volatility - Stock Traders Daily
Can Franklin Genomic Advancements ETF stock attract ESG investmentsMarket Performance Summary & AI Enhanced Trade Execution Alerts - Newser
Is Franklin Genomic Advancements ETF stock vulnerable to rate hikesJuly 2025 Sector Moves & Weekly Chart Analysis and Trade Guides - Newser
Can Franklin Genomic Advancements ETF stock retain market dominance2025 Pullback Review & Reliable Price Breakout Alerts - Newser
EDGAR Filing Documents for 0001133228-25-012986 - SEC.gov
Healthcare ETFs Trounce Tech, Grab Billions As Big Money Flees Bubble Fears - Sahm
The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI - sharewise.com
Best-Performing ETFs of Last Week: Healthcare Rules - sharewise.com
How Franklin Genomic Advancements Etf (HELX) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Is Franklin Genomic Advancements ETF stock positioned for secular growthJuly 2025 Momentum & Short-Term High Return Strategies - newser.com
(HELX) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
How Franklin Genomic Advancements ETF stock compares with tech leadersJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com
Will Franklin Genomic Advancements ETF stock beat growth indexesMarket Weekly Review & Daily Stock Trend Watchlist - newser.com
Finanzdaten der Franklin Genomic Advancements Etf-Aktie (HELX)
Es liegen keine Finanzdaten für Franklin Genomic Advancements Etf (HELX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.35%
Kapitalisierung:
|
Volumen (24h):